These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3423505)

  • 1. Predicting the dynamic effects of rubella vaccination programmes.
    de Boo TM; van Druten JA; Plantinga AD
    Stat Med; 1987; 6(7):843-51. PubMed ID: 3423505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measles, mumps and rubella: control by vaccination.
    van Druten JA; de Boo T; Plantinga AD
    Dev Biol Stand; 1986; 65():53-63. PubMed ID: 3556777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rubella vaccination in India: identifying broad consequences of vaccine introduction and key knowledge gaps.
    Winter AK; Pramanik S; Lessler J; Ferrari M; Grenfell BT; Metcalf CJE
    Epidemiol Infect; 2018 Jan; 146(1):65-77. PubMed ID: 29198212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative investigations of different vaccination policies for the control of congenital rubella syndrome (CRS) in the United Kingdom.
    Anderson RM; Grenfell BT
    J Hyg (Lond); 1986 Apr; 96(2):305-33. PubMed ID: 3701044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computer assessment of alternative rubella vaccination strategies in New Zealand.
    Riseley RC; Smith AH; Laugesen M; Chapman CJ
    N Z Med J; 1983 Apr; 96(729):235-8. PubMed ID: 6572834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Vaccination against mumps and rubella; advice of the Health Council].
    van der Veen J
    Ned Tijdschr Geneeskd; 1984 Jun; 128(24):1150-2. PubMed ID: 6462260
    [No Abstract]   [Full Text] [Related]  

  • 7. A model-based evaluation of the national immunization programme against rubella infection and congenital rubella syndrome in The Netherlands.
    van der Heijden OG; Conyn-van Spaendonck MA; Plantinga AD; Kretzschmar ME
    Epidemiol Infect; 1998 Dec; 121(3):653-71. PubMed ID: 10030716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling the Transmission of Measles and Rubella to Support Global Management Policy Analyses and Eradication Investment Cases.
    Thompson KM; Badizadegan ND
    Risk Anal; 2017 Jun; 37(6):1109-1131. PubMed ID: 28561947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Theoretical aspects of rubella vaccination strategies.
    Knox EG
    Rev Infect Dis; 1985; 7 Suppl 1():S194-7. PubMed ID: 4001728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroprevalence of rubella antibodies in The Netherlands after 32 years of high vaccination coverage.
    Smits G; Mollema L; Hahné S; de Melker H; Tcherniaeva I; van der Klis F; Berbers G
    Vaccine; 2014 Apr; 32(16):1890-5. PubMed ID: 24513012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination against rubella: analysis of the temporal evolution of the age-dependent force of infection and the effects of different contact patterns.
    Amaku M; Coutinho FA; Azevedo RS; Burattini MN; Lopez LF; Massad E
    Phys Rev E Stat Nonlin Soft Matter Phys; 2003 May; 67(5 Pt 1):051907. PubMed ID: 12786178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The decline in congenital rubella syndrome in Western Australia: an impact of the school girl vaccination program?
    Stanley FJ; Sim M; Wilson G; Worthington S
    Am J Public Health; 1986 Jan; 76(1):35-7. PubMed ID: 3940451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination against rubella in Britain: benefits and risks.
    Freestone DS
    Dev Biol Stand; 1979; 43():339-48. PubMed ID: 520680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Success and failure of a rubella immunization programme.
    Swartz TA; Porath EB; Hornstein L
    Dev Biol Stand; 1979; 43():355-60. PubMed ID: 520682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rubella immunity and vaccination coverage of the population of northern Greece in 2006.
    Gioula G; Fylaktou A; Exindari M; Atmatzidis G; Chatzidimitriou D; Melidou A; Kyriazopoulou-Dalaina V
    Euro Surveill; 2007 Nov; 12(11):E9-10. PubMed ID: 18005657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Improvement of rubella vaccination. Seroconversion after serial rubella vaccination with the jet injector].
    Weber HG; Willers H
    Fortschr Med; 1982 Jun; 100(24):1161-3. PubMed ID: 7106679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A simple analysis of vaccination strategies for rubella.
    Buonomo B
    Math Biosci Eng; 2011 Jul; 8(3):677-87. PubMed ID: 21675803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Informing rubella vaccination strategies in East Java, Indonesia through transmission modelling.
    Wu Y; Wood J; Khandaker G; Waddington C; Snelling T
    Vaccine; 2016 Nov; 34(46):5636-5642. PubMed ID: 27670077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolution of rubella vaccine policy for the UK.
    Knox EG
    Int J Epidemiol; 1987 Dec; 16(4):569-78. PubMed ID: 3440667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination with a combined vaccine against measles, mumps and rubella aiming at elimination of the three diseases.
    Böttiger M; Christenson B; Strandell A; Romanus V
    Dev Biol Stand; 1986; 65():37-43. PubMed ID: 3556776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.